SAN DIEGO — A single injection of TLC599, a liposomal formulation of dexamethasone sodium phosphate, bested placebo for osteoarthritis knee pain over 24 weeks, while a second injection extended benefits to week 52, according to data.
“While osteoarthritis is the most common joint disorder in the United States, non-surgical treatment options for knee OA are limited,” David Hunter, MD, of Sydney Musculoskeletal Health, at the University of Sydney, told Healio. “Effective, sustained non-surgical treatment options represent an important unmet medical need for this disorder.”
